loading
Tarsus Pharmaceuticals Inc stock is traded at $70.24, with a volume of 130.09K. It is up +1.89% in the last 24 hours and up +18.22% over the past month. Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
See More
Previous Close:
$68.96
Open:
$68.72
24h Volume:
130.09K
Relative Volume:
0.20
Market Cap:
$2.96B
Revenue:
$17.39M
Net Income/Loss:
$-135.89M
P/E Ratio:
-15.14
EPS:
-4.64
Net Cash Flow:
$-123.00M
1W Performance:
+6.36%
1M Performance:
+18.22%
6M Performance:
+35.35%
1Y Performance:
+57.92%
1-Day Range:
Value
$68.69
$70.84
1-Week Range:
Value
$65.99
$70.84
52-Week Range:
Value
$38.51
$76.81

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
Name
Tarsus Pharmaceuticals Inc
Name
Phone
(949) 409-9820
Name
Address
15440 LAGUNA CANYON ROAD, IRVINE
Name
Employee
323
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TARS's Discussions on Twitter

Compare TARS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TARS
Tarsus Pharmaceuticals Inc
70.22 2.91B 17.39M -135.89M -123.00M -4.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.79 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
655.88 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.12 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
812.69 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.06 41.29B 398.11M -1.03B -868.57M -5.7032

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Resumed Oppenheimer Outperform
May-27-25 Resumed H.C. Wainwright Buy
Nov-20-23 Initiated Goldman Neutral
Jul-18-23 Initiated William Blair Outperform
May-18-23 Initiated Guggenheim Buy
Aug-01-22 Initiated Barclays Overweight
Dec-21-21 Initiated H.C. Wainwright Buy
Nov-23-21 Initiated Oppenheimer Outperform
Nov-10-20 Initiated BofA Securities Buy
Nov-10-20 Initiated Jefferies Buy
Nov-10-20 Initiated Ladenburg Thalmann Buy
Nov-10-20 Initiated Raymond James Strong Buy
View All

Tarsus Pharmaceuticals Inc Stock (TARS) Latest News

pulisher
08:31 AM

Tarsus Pharmaceuticals (TARS) to Release Earnings on Tuesday - MarketBeat

08:31 AM
pulisher
07:04 AM

What to expect from Tarsus Pharmaceuticals Inc. in the next 30 days2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com

07:04 AM
pulisher
06:37 AM

How analysts rate Tarsus Pharmaceuticals Inc. stock todayTrade Signal Summary & Low Risk Entry Point Guides - newser.com

06:37 AM
pulisher
06:34 AM

What’s the recovery path for long term holders of Tarsus Pharmaceuticals Inc.2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com

06:34 AM
pulisher
06:26 AM

Can Tarsus Pharmaceuticals Inc. recover in the next quarterPortfolio Profit Report & Safe Capital Growth Tips - newser.com

06:26 AM
pulisher
06:23 AM

Top chart patterns to watch in Tarsus Pharmaceuticals Inc.CEO Change & Low Risk High Win Rate Stock Picks - newser.com

06:23 AM
pulisher
05:31 AM

Jennison Associates LLC Trims Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat

05:31 AM
pulisher
05:29 AM

Applying sector rotation models to Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com

05:29 AM
pulisher
04:55 AM

Will Tarsus Pharmaceuticals Inc. stock deliver shareholder value2025 Market Overview & Weekly High Return Opportunities - newser.com

04:55 AM
pulisher
04:30 AM

Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Market Outlook & Daily Stock Trend Watchlist - newser.com

04:30 AM
pulisher
03:12 AM

Forecasting Tarsus Pharmaceuticals Inc. price range with options dataIndex Update & Weekly High Momentum Picks - newser.com

03:12 AM
pulisher
Oct 30, 2025

Is Tarsus Pharmaceuticals Inc. stock a safe investment in uncertain marketsTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Tarsus Pharmaceuticals Inc. stock cheap at current valuation2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Tarsus Pharmaceuticals Inc. showing signs of accumulation2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Full technical analysis of Tarsus Pharmaceuticals Inc. stockWeekly Investment Report & Verified Momentum Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 28, 2025

Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q3 2025 Financial Results and Corporate Update - Quiver Quantitative

Oct 28, 2025
pulisher
Oct 28, 2025

Tarsus (NASDAQ: TARS) sets Nov. 4 webcast to share third‑quarter results at 1:30 p.m. PT - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Tarsus Pharmaceuticals Inc. stock attractive for long term wealth building2025 Dividend Review & Technical Entry and Exit Tips - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

How Tarsus Pharmaceuticals Inc. stock performs in weak economy2025 Performance Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Does Tarsus Pharmaceuticals Inc. qualify in momentum factor screening2025 Technical Patterns & Safe Capital Preservation Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Tarsus Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Volume & Low Risk Entry Point Tips - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can Tarsus Pharmaceuticals Inc. stock resist market sell offsSell Signal & Smart Allocation Stock Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase - The Motley Fool

Oct 27, 2025
pulisher
Oct 27, 2025

Tarsus Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Trend Report & Capital Efficiency Focused Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

AlphaQuest LLC Has $836,000 Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat

Oct 27, 2025

Tarsus Pharmaceuticals Inc Stock (TARS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.41
price up icon 1.19%
$28.43
price down icon 0.89%
$93.76
price up icon 1.26%
$103.04
price down icon 1.60%
biotechnology ONC
$309.38
price up icon 0.38%
$189.98
price down icon 2.26%
Cap:     |  Volume (24h):